News | May 25, 2021
Everest Organics launches 'Posaconazole' API
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
The company plans to enter the EU markets in FY22
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
The company has posted net loss of Rs. 99.54 crores for the period ended March 31, 2020
Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production
Subscribe To Our Newsletter & Stay Updated
